A detailed history of Holderness Investments CO transactions in Amgen Inc stock. As of the latest transaction made, Holderness Investments CO holds 6,698 shares of AMGN stock, worth $1.76 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
6,698
Previous 6,070 10.35%
Holding current value
$1.76 Million
Previous $1.9 Million 13.82%
% of portfolio
0.47%
Previous 0.45%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $194,290 - $211,874
628 Added 10.35%
6,698 $2.16 Million
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $127,433 - $154,865
485 Added 8.68%
6,070 $1.9 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $47,321 - $57,122
176 Added 3.25%
5,585 $1.59 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $5,625 - $6,346
22 Added 0.41%
5,409 $1.56 Million
Q3 2023

Nov 15, 2023

BUY
$218.65 - $271.46 $9,620 - $11,944
44 Added 0.82%
5,387 $1.45 Million
Q2 2023

Aug 15, 2023

BUY
$214.27 - $253.37 $34,711 - $41,045
162 Added 3.13%
5,343 $1.19 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $60,060 - $73,203
266 Added 5.41%
5,181 $1.25 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $2,290 - $2,910
-10 Reduced 0.2%
4,915 $1.29 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $53,294 - $59,306
-231 Reduced 4.48%
4,925 $1.2 Million
Q1 2022

May 12, 2022

BUY
$219.27 - $242.57 $62,491 - $69,132
285 Added 5.85%
5,156 $1.25 Million
Q4 2021

Feb 09, 2022

BUY
$198.88 - $227.6 $58,072 - $66,459
292 Added 6.38%
4,871 $1.1 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $14,858 - $17,409
70 Added 1.55%
4,579 $974,000
Q2 2021

Aug 09, 2021

BUY
$233.58 - $259.14 $70,541 - $78,260
302 Added 7.18%
4,509 $1.1 Million
Q1 2021

May 11, 2021

BUY
$221.91 - $258.6 $36,393 - $42,410
164 Added 4.06%
4,207 $1.05 Million
Q4 2020

Feb 05, 2021

SELL
$216.38 - $257.67 $237,152 - $282,406
-1,096 Reduced 21.33%
4,043 $930,000
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $8,682 - $9,655
37 Added 0.73%
5,139 $1.31 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $4,351 - $5,340
-22 Reduced 0.43%
5,102 $1.2 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $72,896 - $96,680
-400 Reduced 7.24%
5,124 $1.04 Million
Q4 2019

Feb 05, 2020

SELL
$189.21 - $243.2 $1,892 - $2,432
-10 Reduced 0.18%
5,524 $1.33 Million
Q3 2019

Nov 01, 2019

SELL
$174.11 - $208.62 $29,598 - $35,465
-170 Reduced 2.98%
5,534 $1.07 Million
Q2 2019

Aug 02, 2019

BUY
$166.7 - $195.41 $8,335 - $9,770
50 Added 0.88%
5,704 $1.05 Million
Q1 2019

May 20, 2019

SELL
$180.87 - $203.88 $1,808 - $2,038
-10 Reduced 0.18%
5,654 $1.07 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $8,028 - $9,371
45 Added 0.8%
5,664 $1.1 Million
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $6,485 - $7,311
35 Added 0.63%
5,619 $1.17 Million
Q2 2018

Aug 16, 2018

SELL
$166.05 - $186.51 $75,884 - $85,235
-457 Reduced 7.56%
5,584 $1.03 Million
Q1 2018

May 10, 2018

BUY
$169.43 - $198.0 $21,348 - $24,948
126 Added 2.13%
6,041 $1.03 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $23,799 - $26,591
141 Added 2.44%
5,915 $1.03 Million
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $965,932 - $1.1 Million
5,774
5,774 $1.08 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Holderness Investments CO Portfolio

Follow Holderness Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holderness Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Holderness Investments CO with notifications on news.